Asthma and Allergy Flashcards

1
Q

Beta2 Adrenergic Agonists- Classification

A

bronchodilator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Beta2 Adrenergic Agonists- Mech of Action

A
  • stimulate adenylyl cyclase causing increase of cAMP resulting in bronchodilatation
  • inhibits relase of mediators from mast cells that cause bronchospasm
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Beta2 Adrenergic Agonists- Route of Administration

A
  • inhalation
  • oral
  • subcutaneous (terbutaline only)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Beta2 Adrenergic Agonists- Therapeutic Use

A
  • symptomatic relief of bronchospasm in acute asthma attacks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Beta2 Adrenergic Agonists- Unique Use

A
  • subcutaneous terbutaline for atatus asthmaticus

- bitolterol for nocturnal asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Beta2 Adrenergic Agonists- Side Effects

A
  • skeletal muscle tremor
  • anxiety
  • tachycardia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Theophylline- Classification

A

bronchodilator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Theophylline- Mech of Action

A
  • inhibits cAMP phophodiesterases causing increase of cAMP resulting in bronchodilation
  • competititive antagonist at adenosine receptors resulting in bronchodilation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Theophylline- Routes of Administration

A
  • oral

- slow IV over 40 min.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Theophylline- Therapeutic Use

A

maintenance therapy for chronic asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Theophylline- Unique Use

A

sustained-release oral theapy for nocternal asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Theophylline- Major Side Effects

A

NARROW THERAPEUTIC INDEX

  • fasciculations
  • generalized convulsions
  • tachycardia
  • circulatory collapse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Ipratropium Bromide- Classification

A

bronchodilator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Ipratropium Bromide- Mech of Action

A
  • antagonist at muscarinic receptors leading to decreased inositol triphosphate, causing decreased release of Ca ions from endoplasmic reticulum resulting in bronchodilatation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Ipratropium Bromide- Routes of Administration

A

inhalation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Ipratropium Bromide- Therapeutic Use

A

alone or in combination with beta2-adrenergic agonist in acute asthma attacks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Ipratropium Bromide- Unique Use

A

when a coexisting chronic bronchitis or cough is the predominant symptom in asthmatic patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Ipratropium Bromide- Side Effects

A

local drying of mouth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Adrenal Corticosteroids- Classification

A

Anti-inflammatory agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Adrenal Corticosteroids- Mech of Action

A
  • increases synthesis of lipomodulin, which inhibits phospholipase A2 which suppresses release of arachidonic acid, which inhibits release of leukotrienes and prostaglandins, resulting in bronchodilatation
21
Q

Adrenal Corticosteroids- Routes of Administration

A
  • inhalation
  • oral
  • IV
22
Q

Adrenal Corticosteroids- Therapeutic Use

A

maintenance therapy for chronic asthma

23
Q

Adrenal Corticosteroids- Unique Use

A

treats the underlying inflammation of asthma, reducing frequency and severity of attacks

24
Q

Adrenal Corticosteroids- Side Effects

A
  • systemic from oral therapy

- local such as oropharyngeal candidiasis, dysphonia, dry mouth and cough from inhalation therapy

25
Cromolyn Sodium- Classification
anti-inflammatory agent
26
Cromolyn Sodium- Mech of Action
decreases Ca influx by IgE Ab and thereby inhibits release of mediators from mast cells that cause bronchospasm
27
Cromolyn Sodium- Routes of Administration
inhalation
28
Cromolyn Sodium- Therapeutic Use
prophylactic therapy for preventing bronchospasm
29
Cromolyn Sodium- Unique Use
- prior to exercise challenge | - prior to cold air challenge
30
Cromolyn Sodium- Side Effects
occasional coughing
31
Zafirlukast- Classification
leukotriene inhibitor
32
Zafirlukast- Mech of Action
complete with LTD4 at its receptor site on airway cells to block bronchoconstriction and inflammation
33
Zafirlukast- Route of Administration
oral (on an empty stomach)
34
Zafirlukast- Therapeutic Use
prophylactic therapy for preventing bronchospasm
35
Zafirlukast- Unique Use
- aspirin-induced asthma | - prior to cold-air challenge
36
Zafirlukast- Side Effects
- headache | - nausea
37
Zileuton- Classification
leukotriene inhibitor
38
Zileuton- Mech of Action
inhibits 5'-lipoxygenase to decrease production of leukotrienes
39
Zileuton- Route of Administration
oral
40
Zileuton- Therapeutic Use
prophylactic therapy for preventing bronchospasm
41
Zileuton- Unique Use
- exercise/aspirin-induced asthma | - nocturnal symptoms/nocturnal asthma
42
Zileuton- Side Effects
contraindicated in patients with hepatic disease
43
Omalizumab- Classification
monoclonal antibody
44
Omalizumab- Mech of Action
forms complex with IgE which lowers serum free IgE preventing release of histamine and leukotrienes from mast cells
45
Omalizumab- Route of Administration
subcutaneous
46
Omalizumab- Therapeutic Use
prophylactic therapy for chronic asthma
47
Omalizumab- Unique Use
none given
48
Omalizumab- Side Effects
possible long-term risk of malignancy